Meta Platforms, Inc. (META)

• Broad-based momentum at scale: TTM revenue growth is +27.7%, Q2 FY26 was +28.0%, and Q3 is modeled around +28%; Family of Apps grew +28.0% YoY and all major regions contributed (US/Canada +29.3%, ROW +35.1%), supporting near-term durability with operating margin at 41.4%.F3E3S1S2F5
• Profitability and balance sheet strength underpin resilience: operating margin 41.4%, net margin 29.8%, interest coverage 38.1x, and net debt/EBITDA 0.68x; dividend coverage remains comfortable.F5F7F6Q3
• Valuation embeds growth but not excess re-rating: forward P/E 21.4x with trailing P/E 27.1x sitting near the 5-year band median (27.4x vs 27.22x), Street mean target $770.26 above the $727.65 price, while FCF yield is a modest 2.46% that limits downside cushion.F8V5W1F1F4V3

En qué se basó el comitéTodas las etapas leyeron un mismo paquete de evidencias construido con documentos de la empresa, datos de mercado, estimaciones de consenso y los hallazgos de los agentes especialistas. Cada afirmación debía citar los elementos en que se basa, y cada cita se contrastó con el paquete.

En qué discrepan las dos tesisUn punto crítico es una cuestión que las dos tesis responden de forma distinta y cuya respuesta cambiaría la opinión. Cada parte argumentó cada punto una vez, con evidencia nueva.

1. 1. Will META sustain near-28% revenue growth into Q3 FY2026 and beyond, or does growth decelerate materially below 25%?

   Se inclina por la tesis alcista

   Reported run-rate is firmly near +28% (TTM +27.7%, Q2 +28.0%) and Q3 is modeled around +28%, with breadth across products and regions supporting near-term continuation; while consensus implies moderation over two years, the dossier does not yet evidence a sub-25% step-down.F3E3S1S2E2
   Leer ambos argumentos

   Tesis alcista

   Sustained near-28% growth looks durable into Q3 and beyond. The run-rate is already in place: TTM revenue growth is 27.7% and Q2 printed 28.0%, with Q3 modeled around 28%.F3E3 Importantly, this is not a one-off rebound from a weak base: FY2025 revenue rose 22.2%, and the subsequent step-up to the current ~28% pace indicates acceleration on top of scale rather than lapping effects.F2 Execution has been consistent, with EPS beating estimates in three of the last four quarters, suggesting disciplined cost and delivery that support growth throughput.E1 Near-term positioning aligns: options skew is strongly bullish into the print, consistent with expectations that momentum holds.O1 Macro is not an acute headwind in our window (neutral outlook: rates low, inflation medium, USD high), reducing the probability that ad demand abruptly undercuts growth to sub-25% near term.M6 Recent relative strength over 3 months further indicates the market is anticipating resilient fundamentals into Q3.P1

   Reconoce: Consensus models a 2-year revenue CAGR of +23.3%, which implies the Street does not underwrite sustained ~28% growth beyond the near term.

   Tesis bajista

   The long case leans on TTM +27.7% and Q2 +28% as proof of durable structural growth, but full-year FY2025 revenue growth was +22.2%, materially below the trailing-twelve-month figure, which shows the recent near-30% prints are an acceleration off easier prior-year comps rather than a new steady-state.F2 As those comps normalize into Q3 and Q4, reversion toward the low-20s FY2025 baseline is at least as plausible as continuation at +28%. Macro specialists flag a sharper-than-expected slowdown in ad spend tied to tighter policy as the single biggest economy-wide risk to META, and price action already shows fragility: over 12 months META is up only +1.5% versus the S&P's +15.1%, a 13.6-point lag that undercuts the narrative of uninterrupted momentum even as the stock ripped +21.3% in the last three months.M7P1 A premium multiple built on extrapolating the current quarter's growth rate is especially vulnerable if Q3's +28% proves to be the cyclical peak rather than the new run-rate, particularly with margin trajectory (41.4% operating) already near structural ceilings.E4

   Reconoce: Regional and segment breadth in the most recent quarter does genuinely support near-term momentum into the Q3 print.

2. 2. Does operating margin remain above 40% or compress below 38%, signaling structural erosion versus temporary investment timing?

   Se inclina por la tesis alcista

   Operating margin sits at 41.4%, with the specialist framing trajectory around current levels; scale advantages and a comfortable balance sheet reduce the need for near-term trade-offs that would drive margins sub-38%.F5E4Q2M1
   Leer ambos argumentos

   Tesis alcista

   Operating margin has held at 41.4%, supported by scale and monetization efficiency that are characteristic of a sector leader with advantaged platform economics.F5M1 The short view presumes AI investment and competitive spend will force margins sub-38%, but the balance sheet indicates capacity to fund growth without destabilizing the income statement; leverage remains comfortable, reducing pressure to chase revenue at the expense of discipline.Q2 Moreover, peer work shows META’s margins are in-line while the valuation debate is bifurcated, suggesting no evidence of unusual cost creep versus direct comps; this undercuts the claim of imminent structural erosion.M4 Broad-based revenue momentum across products and regions helps keep fixed-cost absorption high, reinforcing operating leverage at scale.S1S2 Into the next print, margin trajectory is framed around the current level rather than deterioration, consistent with the latest specialist read.E4 Net: leadership position, prudent financing posture, and at-scale ad economics argue for margins staying near ~41% rather than breaking below 38%.F5M1Q2M4

   Reconoce: We lack filed visibility on how upcoming AI initiatives will flow through opex versus capex in the next few quarters, limiting precision on near-term margin path.

   Tesis bajista

   The long side rests on 41.4% being durable, but that figure is a trailing current level, not a forward guarantee, and Reality Labs continues to post losses embedded within consolidated margins even as its revenue share is tiny (0.7% of product revenue) — meaning Family of Apps margins are already shouldering heavy offsetting investment, leaving less room to absorb incremental AI capex before consolidated margin cracks.S1 Meta's own 10-K flags infrastructure scaling risk directly: 'our business is dependent on our ability to maintain and scale our technical infrastructure, and any significant disruption... could damage our reputation, result in a potential loss of users and engagement', which is precisely the kind of spend-intensive buildout that pressures margins if monetization lags capex timing.R4 Layer on a negative PEG of -5.55, implying the market has essentially zero tolerance for an earnings miss, and even a modest margin step-down toward 38% would reprice the stock sharply given how little cash-yield cushion exists.V4 The long view's reliance on a single current-quarter margin snapshot ignores that capex-driven compression often shows up with a lag.

   Reconoce: Current filings show no quarter-over-quarter margin deterioration yet, so the compression thesis remains forward-looking rather than evidenced in reported numbers.

3. 3. Do insider transactions shift to net discretionary buying, or do 10b5-1 dispositions persist, signaling confidence divergence at current valuations?

   Se inclina por la tesis bajista

   Recent activity shows 52 dispositions vs 1 purchase over 90 days and no discretionary insider buys, with sales largely pre-planned; at a record price, this pattern argues that a pivot to net discretionary buying is unsubstantiated today.Q1H2F1
   Leer ambos argumentos

   Tesis alcista

   The short side’s best point is the recent imbalance — 52 sales vs 1 buy and net -117,553 shares — which, on the surface, reads as skepticism at today’s premium multiple.Q1 However, Form 4 detail characterizes the sales as predominantly pre-planned 10b5-1 activity with no discretionary insider buying, leaving the net signal neutral rather than actively bearish on valuation.H2 With Q3 earnings on 2026-10-28, insiders are typically constrained by blackout windows, which can suppress discretionary buying ahead of a major catalyst.T1 Options markets price a wide 30-day one-sigma band (±14.2%), underscoring event risk and creating a rational incentive for insiders to pause sales — or selectively add — once visibility improves post-print.O4 If execution and outlook remain intact, a post-earnings lift in discretionary activity (buys or at least a pause in open-market sales) is a credible next step, aligning insider behavior with management’s confidence rather than signaling a valuation rift.

   Reconoce: There is no filed evidence yet of any shift toward discretionary insider buying, and recent activity remains heavily net negative on a share-count basis.

   Tesis bajista

   The long case for a discretionary-buying shift has no supporting data point in this dossier; the record remains 52 sales against a single purchase, net -117,553 shares over 90 days, with the lone discretionary item tied to a Deriva conversion rather than an open-market conviction buy.Q1H2 Pre-planned 10b5-1 status does not neutralize the signal when it is this one-sided and persistent into an earnings catalyst dated 2026-10-28: if insiders believed the post-print setup favored upside, a pause or a buy would be the rational move, especially with options already pricing a ±5.1% seven-day move around that date.T1O3 Instead, selling continued through a period when the stock traded at a record price, which is consistent with insiders treating current levels as a liquidity window rather than undervalued.F1 The simplified DCF, however assumption-sensitive, also lands two-thirds below market price, reinforcing that internal actors are not alone in seeing the multiple as rich.F10 Nothing here supports the long's optimism about an imminent confidence pivot.

   Reconoce: Pre-planned 10b5-1 sales do carry weaker signal value than fully discretionary dispositions, so the dossier cannot rule out that some selling reflects routine diversification unrelated to valuation views.

Revisiones del comitéRevisores independientes ponen a prueba el expediente antes de redactar el memorando: un pre-mortem de cada tesis, una revisión de posicionamiento y volatilidad, y una auditoría de cada cita.

Qué haría que el comité revisara esta opiniónDetonantes de investigación: hechos observables, con fecha cuando un catalizador lo permite, que reabrirían la opinión. No son instrucciones de negociación.

• 28 oct 2026Q3 revenue growth undershoots the modeled run-rateE3C1
• 28 oct 2026Operating margin slips below the current reported levelF5C1E4
• En cursoPrice de-rates through options-implied 30D lower bandO4
• En cursoInsiders remain one-sided net sellers post-earnings with no discretionary buysQ1H2

Son detonantes de investigación, no instrucciones de negociación.